High serum osteopontin levels are associated with low bone mineral density in postmenopausal women

Journal of Korean Medical Science

Volumn 28, Issue 10, 2013, Pages 1496-1499

  Cho, Eun Hee ^a   Cho, Keun Hyok ^a   Lee, Hyang Ah ^a   Kim, Sang Wook ^a  

^a Kangwon National University   (South Korea)

Author keywords

Bone mineral density; Fragility fracture; Postmenopause; Serum osteopontin levels

Indexed keywords

OSTEOPONTIN;

AGED; ARTICLE; BLOOD; BONE DENSITY; FEMALE; FEMUR NECK; FRACTURE; FRAGILITY FRACTURE; HUMAN; METABOLISM; MIDDLE AGED; PATHOLOGY; PHYSIOLOGY; POSTMENOPAUSE; PREMENOPAUSE; SERUM OSTEOPONTIN LEVELS; SPINE; STATISTICAL MODEL;

BONE MINERAL DENSITY; FRAGILITY FRACTURE; POSTMENOPAUSE; SERUM OSTEOPONTIN LEVELS;

AGED; BONE DENSITY; FEMALE; FEMUR NECK; FRACTURES, BONE; HUMANS; LINEAR MODELS; MIDDLE AGED; OSTEOPONTIN; POSTMENOPAUSE; PREMENOPAUSE; SPINE;

EID: 84885702340     PISSN: 10118934     EISSN: 15986357     Source Type: Journal    
DOI: 10.3346/jkms.2013.28.10.1496     Document Type: Article

References (17)

1. Chang YS, Kim HJ, Chang J, Ahn CM, Kim SK, Kim SK. Elevated circulating level of osteopontin is associated with advanced disease state of non-small cell lung cancer. Lung Cancer 2007; 57: 373-80.
2. Weber GF, Lett GS, Haubein NC. Osteopontin is a marker for cancer aggressiveness and patient survival. Br J Cancer 2010; 103: 861-9.
3. Gómez-Ambrosi J, Catalán V, Ramírez B, Rodríguez A, Colina I, Silva C, Rotellar F, Mugueta C, Gil MJ, Cienfuegos JA, et al. Plasma osteopontin levels and expression in adipose tissue are increased in obesity. J Clin Endocrinol Metab 2007; 92: 3719-27.
4. Nomiyama T, Perez-Tilve D, Ogawa D, Gizard F, Zhao Y, Heywood EB, Jones KL, Kawamori R, Cassis LA, Tschöp MH, et al. Osteopontin mediates obesity-induced adipose tissue macrophage infiltration and insulin resistance in mice. J Clin Invest 2007; 117: 2877-88.
5. Scatena M, Liaw L, Giachelli CM. Osteopontin: a multifunctional molecule regulating chronic inflammation and vascular disease. Arterioscler Thromb Vasc Biol 2007; 27: 2302-9.
6. Ishijima M, Ezura Y, Tsuji K, Rittling SR, Kurosawa H, Denhardt DT, Emi M, Nifuji A, Noda M. Osteopontin is associated with nuclear factor kappaB gene expression during tail-suspension-induced bone loss. Exp Cell Res 2006; 312: 3075-83.
7. Ishijima M, Rittling SR, Yamashita T, Tsuji K, Kurosawa H, Nifuji A, Denhardt DT, Noda M. Enhancement of osteoclastic bone resorption and suppression of osteoblastic bone formation in response to reduced mechanical stress do not occur in the absence of osteopontin. J Exp Med 2001; 193: 399-404.
8. Yoshitake H, Rittling SR, Denhardt DT, Noda M. Osteopontin-deficient mice are resistant to ovariectomy-induced bone resorption. Proc Natl Acad Sci U S A 1999; 96: 8156-60.
9. Denhardt DT, Noda M, O'Regan AW, Pavlin D, Berman JS. Osteopontin as a means to cope with environmental insults: regulation of inflammation, tissue remodeling, and cell survival. J Clin Invest 2001; 107: 1055-61.
10. Chellaiah MA, Kizer N, Biswas R, Alvarez U, Strauss-Schoenberger J, Rifas L, Rittling SR, Denhardt DT, Hruska KA. Osteopontin deficiency produces osteoclast dysfunction due to reduced CD44 surface expression. Mol Biol Cell 2003; 14: 173-89.
11. Nagao M, Feinstein TN, Ezura Y, Hayata T, Notomi T, Saita Y, Hanyu R, Hemmi H, Izu Y, Takeda S, et al. Sympathetic control of bone mass regulated by osteopontin. Proc Natl Acad Sci U S A 2011; 108: 17767-72.
12. Chang IC, Chiang TI, Yeh KT, Lee H, Cheng YW. Increased serum osteopontin is a risk factor for osteoporosis in menopausal women. Osteoporos Int 2010; 21: 1401-9.
13. Fodor D, Bondor C, Albu A, Simon SP, Craciun A, Muntean L. The value of osteopontin in the assessment of bone mineral density status in postmenopausal women. J Investig Med 2013; 61: 15-21.
14. Zhao JJ, Yang L, Zhao FQ, Shi SM, Tan P. Osteopontin levels are elevated in patients with asthma. J Int Med Res 2011; 39: 1402-7.
15. Constantinescu D, Vornicu M, Grigoriu C, Cozmei C, Grigoriu BD. Assaying for circulating osteopontin in practice: a technical note. Eur Respir J 2010; 35: 1187-8.
16. Mazzone A, Parri MS, Giannessi D, Ravani M, Vaghetti M, Altieri P, Casalino L, Maltinti M, Balbi M, Barsotti A, et al. Osteopontin plasma levels and accelerated atherosclerosis in patients with CAD undergoing PCI: a prospective clinical study. Coron Artery Dis 2011; 22: 179-87.
17. Samitas K, Zervas E, Vittorakis S, Semitekolou M, AlissafiT, Bossios A, Gogos H, Economidou E, Lötvall J, Xanthou G, et al. Osteopontin expression and relation to disease severity in human asthma. Eur Respir J 2011; 37: 331-41.